×

Concerned about your own or
someone else’s drug use?

Fellowship Program

NCCRED has developed a multidisciplinary mentoring and training program. In our inaugural year, 3 Research Fellows have been selected from a competitive application process. Fellows can be clinicians of any multidisciplinary background (e.g. Nursing, Allied Health, Medical), practicing in the Alcohol and Other Drugs sector. The candidates are partnered with a senior clinician-researcher. NCCRED have contribute to the Research Fellow’s salary in a 0.5 FTE “buy-back”, whereby they replace the candidate’s salary from their primary employment for the 1-year fellowship term.

Current NCCRED Clinical Research Fellows

Dr Andrew Kozman

Fellow

Bio

Dr. Andrew Kozman is an emergency consultant based in Perth, WA, working at one of the busiest and largest emergency departments in Australia. His main interest

Bio

Dr. Andrew Kozman is an emergency consultant based in Perth, WA, working at one of the busiest and largest emergency departments in Australia. His main interest in emergency care lies in the recognition and management of toxicological presentations. He’s working towards a clinical toxicologist role, completing a Masters of Clinical Toxicology to complement a prior degree in Pharmacy. In the long-term, Dr. Kozman aspires to lead a toxicology unit to manage and offer world-leading care for patients presenting to emergency with NPS and other drug overdose. His fellowship with NCCRED is a step toward building a national network to unify the emergency response and knowledge base when it comes to responding to emerging drugs of concern.

 

Project

With an ever-increasing number of novel psychoactive substances (NPS) being detected world-wide, clusters of severely unwell patients are presenting to Emergency Departments. There are serious and significant concerns about morbidity and mortality from amphetamine and an increasing array of NPS. The NCCRED fellowship will allow Dr. Kozman to:

  1. Develop a clinical protocol for Western Australian Metropolitan Emergency Departments to collect samples from recreational drug presentations derived from the Western Australian Illicit Substance Evaluation (WISE) study developed at Royal Perth Hospital (RPH) in 2016
  2. Determine the patterns and clusters in the numbers of samples positive for illicit substances and NPS, as identified by Chem Laboratories in patients presenting with drug intoxication
  3. Assess the most useful form of clinical and toxicological information that can contribute to the various early warning systems and prompt response networks that are currently being developed in WA, and nationally

This contribute to a national registry and early warning system, culminating in the Emerging Drugs Network of Australia (EDNA); and the Prompt Response Network. This will allow collaboration between prehospital services and health departments; timely notification of acute events; and inform clinical and public health policy.

Read more

Dr Edward Mullen

Fellow

Bio

Dr Eddie Mullen is a consultant psychiatrist working with young people aged 15-25 at Orygen Specialist Services, an Early Intervention program based in Western

Bio

Dr Eddie Mullen is a consultant psychiatrist working with young people aged 15-25 at Orygen Specialist Services, an Early Intervention program based in Western Melbourne since 2013. He specialises in working with young people with a dual diagnosis of substance use and mental health disorders as well as with severe Borderline Personality Disorder. Dr Mullen provides clinical care to young people with substance use disorders as well as training staff in brief interventions, smoking cessation and opiate overdose prevention. He has presented a part of substance use symposia at international meetings such as the Congress of the World Psychiatric Association and the International Society for Study of Personality Disorders.

Dr Mullen is a member of the Substance Use Research Group at Orygen and an investigator on 3 clinical trials related to smoking cessation and methamphetamine abuse. He is interested in researching the link between substance use and mental health disorders, new treatments for young people and improving knowledge of harms associated with substance use. Dr Mullen is also member of the Royal Australia and New Zealand College of Psychiatrists Alcohol Harms Advisory Working Group that is currently developing a public campaign to raise awareness of the links between alcohol use and mental health issues and the role of psychiatrists in treatment and recovery.

 

Project

MethAmphetamine use in young people: Sub-anaesthetic Ketamine Open-label Trial (MASKOT).

Dr Mullen will conduct a clinical trial of ketamine for methamphetamine use in youth. He will complete his fellowship under the mentorship of Dr Gillinder Bedi, Head of Substance Use Research at Orygen, and a Senior Research Fellow of University of Melbourne. The fellowship will involve the protocol design, and the ethical and clinical governance approval; a systematic literature review of other pharmacotherapies for substance abuse in youth; and the governance and implementation. He will also assist in the design of a new Research Project Data Management System for collecting and analysing completed project data.

Read more

Dr Adam Rubenis

Fellow

Bio

Do Telehealth interventions offer a more accessible form of treatment with a similar level of efficacy when compared to face-to-face support? While a Telehealth

Bio

Do Telehealth interventions offer a more accessible form of treatment with a similar level of efficacy when compared to face-to-face support? While a Telehealth approach may increase accessibility to treatment on one level, other complex factors may continue to impact retention. At Turning Point, Adam Rubenis will explore acceptability of novel strategies for increasing retention in a structured Telehealth program for people with methamphetamine use disorder.

 

Project

Adam completed a Bachelor of Arts (Hons.), initially studying Journalism before shifting to psychology, where he completed a Doctorate in Clinical Psychology at Monash University in 2018. His research focused on links between cognitive functioning and treatment outcomes in methamphetamine-dependent individuals. His thesis identified some elements of cognitive function (i.e., attentional function, delay discounting and impulsive action) that are predictive of treatment outcomes, where poorer function was associated with poorer outcomes. Since graduating, he’s worked at Turning Point in Melbourne, completing my clinical psychology registrar program and working across telehealth and face-to-face programs, supporting people with substance use/gambling concerns and mental health needs. In this role he’s also been involved in evaluating one of our treatment programs and contributed to the most recent edition of the Methamphetamine Treatment Guidelines.

Read more

Fellowship Information:

  • Fellows can be clinicians of any multidisciplinary background in the AoD sector (e.g. Nursing, Allied Health, Medical)  
  • The candidate will be partnered with a senior clinician-researcher either chosen by the applicant (if there is a preferred established partnership) or in collaboration with NCCRED staff
  • NCCRED will contribute to the fellow’s salary in a 0.5 FTE “buy-back”, whereby they replace the candidate’s salary for the 1-year fellowship term
  • A research project will be identified in collaboration between the fellow, their mentor, the NCCRED Director, and the Chair of the NCCRED Board
  • This will be an iterative process that will be informed by the fellow’s experience, interest, and career aspirations 

Applications are currently closed for NCCRED Fellows. But please sign up to our newsletter, or contact us below for more information.

All expressions of interest are welcome. Our next round of fellowships will look to focus on nursing and indigenous health. 

Contact Us